Urinary angiotensinogen, related factors and clinical implications in normotensive autosomal dominant polycystic kidney disease patients

References

• Evan AP, Gardner KD, Bernstein J. Polypoid and papillary epithelial hyperplasia: a potential cause of ductal obstruction in adult polycystic kidney disease. Kidney Int. 1979;16:743–750
   PubMedGoogle Scholar
• Gabow PA, Johnson AM, Kaehny WD, et al. Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. Kidney Int. 1992;41:1311–1319
   PubMed Web of Science ®Google Scholar
• Wang D, Strandgaard S. The pathogenesis of hypertension in autosomal dominant kidney disease. J Hypertens. 1997;15:925–933
   PubMed Web of Science ®Google Scholar
• Watson ML, Macnicol AM, Allan PL, Wright AF. Effects of angiotensin converting enzyme inhibition in adult polycystic kidney disease. Kidney Int. 1992;41:206–210
   PubMed Web of Science ®Google Scholar
• Graham PC, Lindop GB. The anatomy of the renin-secreting cell in adult polycystic kidney disease. Kidney Int. 1988;33:1084–1090
   PubMed Web of Science ®Google Scholar
• Torres VE, Donovan KA, Scicli G, et al. Synthesis of renin by tubulocystic epithelium in autosomal dominant polycystic kidney disease. Kidney Int. 1992;42:364–373
   PubMedGoogle Scholar
• Loghman-Adham M, Soto CE, Inagami T, Cassis L. The intrarenal renin-angiotensin system in autosomal dominant polycystic kidney disease. Am J Physiol. 2004;287:F775–F788
   PubMed Web of Science ®Google Scholar
• Kobori H, Harrison-Bernard LM, Navar LG. Urinary excretion of angiotensinogen reflects intrarenal angiotensinogen production. Kidney Int. 2002;61:579–585
   PubMed Web of Science ®Google Scholar
• Kobori H, Nishiyama A, Harrison-Bernard LM, Navar LG. Urinary angiotensinogen as an indicator for intrarenal angiotensin status in hypertension. Hypertension. 2003;41:42–49
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Nakagawa T, Suzuki H, et al. Urinary angiotensinogen as a marker of intrarenal angiotensin II activity association with deterioration of renal function in patients with chronic kidney disease. J Am Soc Nephrol. 2007;18:1558–1565
   PubMed Web of Science ®Google Scholar
• Nishiyama A, Konishi Y, Ohashi N, et al. Urinary angiotensinogen reflects the activity of intrarenal renin-angiotensin system in patients with IgA nephropathy. Nephrol Dial Transplant. 2011;26:170--171
   PubMed Web of Science ®Google Scholar
• Erdogmus S, Sengul S, Kocak S, et al. Urinary angiotensinogen level is correlated with proteinuria in renal transplant recipients. Transpl Proc. 2013;45(3):935–939
   PubMedGoogle Scholar
• Aybal Kutlugun A, Altun B, Buyukasik Y, et al. Elevated urinary angiotensinogen a marker of intrarenal renin angiotensin system in hypertensive renal transplant recipients: does it play a role in development of proteinuria in hypertensive renal transplant patients? Transpl Int. 2012;25(1):13–18
   PubMedGoogle Scholar
• Pei Y, Obaji J, Dupuis A, et al. Unified criteria for ultrasonographic diagnosis of ADPKD. J Am Soc Nephrol. 2009;20(1):205–212
   PubMed Web of Science ®Google Scholar
• Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in Renal Disease Study Group (PDF). Ann Intern Med. 1999;130:461--470
   PubMed Web of Science ®Google Scholar
• Kobori H, Nangaku M, Navar LG, Nishiyama A. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev. 2007;59:251–287
   PubMed Web of Science ®Google Scholar
• Van den Heuvel M, Batenburg WW, Jainandunsing S, et al. Urinary renin, but not angiotensinogen or aldosterone, reflects the renal renin–angiotensin–aldosterone system activity and the efficacy of renin-angiotensin-aldosterone system blockade in the kidney. J Hypertens. 2011;29(11):2147–2155
   PubMedGoogle Scholar
• Roksnoer LC, Verdonk K, van den Meiracker AH, Hoorn EJ, Zietse R, Danser AH. Urinary markers of intrarenal renin-angiotensin system activity in vivo. Curr Hypertens Rep. 2013;15(2):81–88
   PubMedGoogle Scholar
• Kobori H, Ohashi N, Katsurada A, et al. Urinary angiotensinogen potential biomarker of severity of chronic kidney diseases. J Am Soc Hypertens. 2008;2:349–354
   PubMed Web of Science ®Google Scholar
• Saito T, Urushihara M, Kotani Y, Kagami S, Kobori H. Increased urinary angiotensinogen is precedent to increased urinary albumin in patients with Type 1 diabetes. Am J Med Sci. 2009;338:478–480
   PubMed Web of Science ®Google Scholar
• Nakano D, Kobori H, Burford JL, et al. Multiphoton imaging of the glomerular permeability of angiotensinogen. J Am Soc Nephrol. 2012;23(11):1847–1856
   PubMedGoogle Scholar
• Loon N, Shemesh O, Morelli E, Myers BD. Effect of angiotensin II infusion on the human glomerular filtration barrier. Am J Physiol. 1989;257:F608–F614
   Google Scholar
• Pagtalunan ME, Rasch R, Rennke HG, Meyer TW. Morphometric analysis of effects of angiotensin II on glomerular structure in rats. Am J Physiol. 1995;268:F82–F88
   Google Scholar
• Hoffmann S, Podlich D, Hahnel B, Kriz W, Gretz N. Angiotensin II type 1 receptor overexpression in podocytes induces glomerulosclerosis in transgenic rats. J Am Soc Nephrol. 2004;15:1475–1487
   PubMed Web of Science ®Google Scholar
• Whaley-Connell A, Chowdhury N, Hayden MR, et al. Oxidative stress and glomerular filtration barrier injury: role of the renin-angiotensin system in the Ren2 transgenic rat. Am J Physiol. 2006;291:F1308–F1314
   PubMed Web of Science ®Google Scholar
• Durvasula RV, Petermann AT, Hiromura K, et al. Activation of a local tissue angiotensin system in podocytes by mechanical strain. Kidney Int. 2004;65:30–39
   PubMed Web of Science ®Google Scholar
• Liang XB, Ma LJ, Naito T, et al. Angiotensin type 1 receptor blocker restores podocyte potential to promote glomerular endothelial cell growth. J Am Soc Nephrol. 2006;17:1886–1895
   PubMedGoogle Scholar
• Kuroczycka-Saniutycz E, Wasilewska A, Sulik A, Milewski R. Urinary angiotensinogen as a marker of intrarenal angiotensin II activity in adolescents with primary hypertension. Pediatr Nephrol. 2013;28(7):1113–1119
   PubMedGoogle Scholar
• Zou J, Li Y, Li FH, Wei FF, Wang JG. Urinary angiotensinogen excretion and ambulatory blood pressure. J Hypertens. 2012;30(10):2000--2006
   PubMedGoogle Scholar
• Navar LG, Nishiyama A. Intrarenal formation of angiotensin II. Contrib Nephrol. 2001;135:1–15
   Google Scholar
• Ichihara H, Kobori H, Nishiyama A. Renal renin–angiotensin system. Contrib Nephrol. 2004;143:117–130
   PubMed Web of Science ®Google Scholar
• Deschepper CF. Angiotensinogen. Hormonal regulation and relative importance in the generation of angiotensin II. Kidney Int. 1994;46:1561–1563
   PubMed Web of Science ®Google Scholar
• Brasier AR, Li J. Mechanisms for inducible control of angiotensinogen gene transcription. Hypertension. 1996;27:465–475
   PubMed Web of Science ®Google Scholar